Hyo-Yeon Kim

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma

S. Paik, M. Ahn, B. Cho, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Updated safety and efficacy results from phase I/II study of HM61713 in patients (pts) with EGFR mutation positive non-small cell lung cancer (NSCLC) who failed previous EGFR-tyrosine kinase inhibitor (TKI).

Keunchil Park, E. Cho, Dong-Wan Kim, 2015 .

Impaired phagocytosis of apoptotic cells causes accumulation of bone marrow-derived macrophages in aged mice

G. Cheon, Dongki Yang, O. Kim, 2017, BMB reports.